Lenacapavir, a new twice-yearly injection, offers 96% HIV prevention efficacy, surpassing daily oral PrEP. For oral ...

It’s been called the closest the world has ever come to a vaccine against AIDS. The twice-yearly shot was 100% effective in ...

Another drugmaker, Viiv Healthcare, also left out most of Latin America when it allowed generics of its HIV prevention shot ...

Current health news highlights include Sanofi's $1 billion investment in a Beijing insulin site, New Zealand's poultry export ...

The drug has been called a profound advancement in medicine but getting it to those who need it is a "missing piece in the ...

Argentina's HIV patients and healthcare providers voice concerns over spending cuts by President Javier Milei, fearing ...